LRRC15 and pulmonary fibrosis: Moreover, the presence of LRRC15+ myofibroblasts in other, non-neoplastic diseases, such as idiopathic pulmonary fibrosis and ulcerative colitis10, suggests that such a therapeutic approach may be broadened to provide patient benefit in other disease areas.